Skip to content

The development of treatment using decoded neurofeedback for patients with PTSD

The development of treatment using decoded neurofeedback for patients with PTSD - The development of treatment using decoded neurofeedback for patients with PTSD

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028148
Enrollment
30
Registered
2017-07-15
Start date
2017-07-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic stress disorder (PTSD)

Interventions

fMRI neurofeedback using a 3T fMRI apparatus

Sponsors

Osaka Medical and Pharmaceutical University
Lead Sponsor
Advanced Telecommunications Research Institute International (ATR) National defense medical college Japan ground self-force, Test and evaluation command, Military Medicine Research Unit Self-Defense Forces Central Hospital Kokoro to Karada Hikarinohana clinic Seven mental clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. DSM-IV-TR diagnosis of PTSD 2. Normal visual acuity 4. Aged 20-50 years-old, outpatients, 5. Capability of informed consent

Exclusion criteria

Exclusion criteria: Implanted cardiac pacemaker Surgical aneurysm clips Neurostimulator Implanted pumps Metal fragments in body/eyes Tattoos or permanent eyeliner (if ink contains metallic specks) Treatment history of ECT Diagnosis of neurological disorders (including epilepsy), substance dependence, or significant cardiac disease History of neurological disorders (including epilepsy), substance dependence, or head injury with loss of consciousness Pregnancy. Suspicion of pregnancy. Breast-feeding. Incapability of contraception during experiment. Doctors diagnose danger.

Design outcomes

Primary

MeasureTime frame
Clinician-Administered PTSD scale

Secondary

MeasureTime frame
Skin conductance response to traumatic stimuli Amygdala response to traumatic stimuli

Countries

Japan

Contacts

Public ContactTetsufumi Kanazawa

Osaka Medical and Pharmaceutical University Neuropsychiatry

tk@ompu.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026